CA
NZ
UK
AU
IND
US
Dyne Therapeutics (NASDAQ:DYN) shares are pulling back sharply in pre-market trading after RBC cut its price target on the stock to $30 from $35, though the firm maintained its Outperform rating with a Speculative Risk qualifier. Dyne Therapeutics is a clinical-stage biotechnology company dedicated …
Evommune (NYSE:EVMN) shares are falling sharply in pre-market trading after the company announced topline results from its Phase 2b trial evaluating EVO756 in adults with moderate-to-severe atopic dermatitis, which did not meet its primary endpoint of percent change in Eczema Area and Severityindexscore from …
Opus Genetics (NASDAQ:IRD) shares are trading higher in pre-market trading after the company reported positive low-dose Cohort 1 data from its ongoing Phase 1/2 BIRD-1 trial evaluating OPGx-BEST1 in patients with BEST1-related retinal diseases, including Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Opus …
A NASDAQ-listed outpatient mental health care provider is trading lower in pre-market trading after announcing a secondary public offering by existing stockholders. LifeStance Health Group (NASDAQ:LFST) disclosed that certain existing stockholders intend to sell 22,250,000 shares of common stock, with the selling stockholders receiving …
MannKind (NASDAQ:MNKD) shares are trading higher in pre-market trading after the company announced a worldwide licensing and collaboration agreement with Rose Pharma to develop ROSE-010 Technosphere, an inhaled, rapid-acting glucagon-like peptide-1 receptor agonist for weight management. MannKind is a biopharmaceutical company focused on developing …
Immuron Limited (NASDAQ: IMRN) shares closed up 62% at $1.80 after the company entered an exclusive distribution agreement within the United States with Calmino Group AB for PROIBS.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares closed up 27% at $0.51 after the company unveiled a refined PrimeC development plan for ALS, leveraging AI-driven formulation insights and a streamlined Phase 3 PARAGON trial design.
Clearmind Medicine Inc. (NASDAQ: CMND) shares closed down 32% at $1.16 after the company entered a definitive agreement to acquire a 51% stake in EV wireless charging company Charging Robotics for $2.5 million plus a $1.5 million 4% loan.
Nano-X Imaging Ltd. (NASDAQ: NNOX) shares closed up 16% at $0.83 afterSubsidiaryNanox Impact entered a regional distribution partnership with Associated X-Ray Imaging to commercialize and maintain the Nanox.ARC 3D digital tomosynthesis system across New England.
Aethlon Medical, Inc. (NASDAQ: AEMD) shares closed down 6% at $1.82 despite the company securing a notice of allowance from the USPTO for a patent regarding technology for managing viral infections and their symptoms.
Please wait processing your request...